Sun pharma acquires us-based pharmalucence
The US based company operated in the area of sterile injectable capacity.
New Delhi, July 16, 2014: The Indian drug firm Sun Pharmaceuticals has acquired Pharmalucence Inc. The US-based company is into sterile injectable capacity and has been acquired by one of the subsidiaries of Sun Pharma.
It may be recalled that Sun Pharma also acquired Ranbaxy Laboratories in an al stock transaction with a total equity value of US$ 3.2 billion and a debt of US$ 800 million.
Sun Pharma did not disclose the financials involved in the acquisition of Pharmalucence Inc.